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ScienceDirectIn the prokaryotic CRISPR-Cas adaptive immune systems, a
CRISPR RNA (crRNA) assembles with multiple or single Cas
proteins to form crRNA ribonucleoprotein (crRNP) effector
complexes, responsible for the destruction of invading genetic
elements. Although the mechanisms of target recognition and
cleavage by the crRNP effectors are quite diverse among the
different types of CRISPR-Cas systems, the basic action
principles of these crRNA-guided effector nucleases are highly
conserved. In all of the crRNP effectors, the repeat-derived
invariant and spacer-derived variable segments of the crRNA are
recognized by the Cas protein(s) in sequence-dependent and
sequence-independent manners, respectively, with the spacer-
derived guide segment available for base pairing with target
nucleic acids. Over the past few years, intensive studies have
provided an atomic view of the crRNA-guided target interference
mechanisms in different types of CRISPR-Cas systems. Here,
we review the recent progress toward structural and mechanistic
understanding of the diverse crRNP effector nucleases.
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Introduction
Prokaryotes utilize CRISPR-Cas (clustered regularly
interspaced short palindromic repeats and CRISPR-asso-
ciated) adaptive immune systems to combat foreign ge-
netic elements, such as plasmids and phages [1–4]. In the
CRISPR-Cas systems, a small CRISPR RNA (crRNA)
and single or multiple Cas proteins form crRNA ribonu-
cleoprotein (crRNP) effector complexes, and play central
roles in the destruction of invading nucleic acidsCurrent Opinion in Structural Biology 2017, 43:68–78 (Figure 1). The Cas proteins and crRNAs are encoded
by the cas operon and the CRISPR array in the CRISPR
loci, respectively. The CRISPR array comprises short
repetitive sequences (direct repeats) separated by non-
repetitive sequences (spacers) derived from foreign ge-
netic elements, and is transcribed into precursor crRNAs,
which are further processed into mature crRNAs. The
crRNAs consist of a spacer and a portion of the adjacent
direct repeat (Figure 1). In most cases, the crRNA repeat
regions have identical sequences, and adopt a distinct
structure that is recognized by the effector Cas proteins in
a sequence-specific manner. By contrast, the crRNA
spacers have diverse sequences that are recognized by
the effector Cas proteins in a non-sequence-specific man-
ner, with their Watson-Crick edges available for base
pairing with nucleic acid targets. Thus, the crRNAs serve
as a guide to direct the crRNP effectors to the target for
degradation. Target recognition by most of the crRNP
effectors requires the presence of a short nucleotide
sequence near the target sequence, called the protospacer
adjacent motif (PAM). The CRISPR-Cas systems are
divided into two classes, which is further divided into
six types and 19 subtypes [3,5,6]. The crRNP effectors in
the class 1 system (types I, III and IV) employ multiple
Cas proteins, whereas the crRNP effectors in the class
2 system (types II, V and VI) utilize a single Cas protein
(Figure 1). Structural studies have revealed the remark-
ably diverse and sophisticated mechanisms of target
degradation by the crRNP effector nucleases in the
different types of CRISPR-Cas systems (for reviews,
see [7–9]). In this review, we describe the recent progress
toward structural and mechanistic understanding of the
diverse crRNP effector nucleases.
Class 1 system
Type I Cascade–Cas3 effector complex
In the type I-E system from Escherichia coli, the 405-kDa
multisubunit surveillance complex, Cascade (CRISPR-
associated complex for antiviral defense), is responsible
for the degradation of foreign genetic elements [10].
Cascade consists of five Cas protein subunits (Cse1,
Cse2, Cas5e, Cas6e and Cas7) and a 61-nt crRNA, with
a stoichiometry of Cse11Cse22Cas5e1Cas6e1Cas76-
crRNA1 [11] (Figure 2a). Cascade mediates the
crRNA-guided unwinding of a double-stranded (ds)
DNA target to facilitate R-loop formation, and recruits
the Cas3 helicase-nuclease for target degradation [12].
In 2011, the 8 A˚ resolution cryo-electron microscopy
(cryo-EM) structure revealed that Cascade adopts awww.sciencedirect.com
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Various types of crRNP effector nucleases. The repeats and spacers in the CRIPSR locus are shown in orange and different colors, respectively.
The repeat-derived region and the spacer-derived guide segment in the crRNAs are colored orange and red, respectively. The tracrRNA in the
type II system is colored pink.seahorse-shaped architecture [13]. In 2014, the crystal
structures of Cascade alone [14,15] and in complex
with a single-stranded (ss) DNA target [16] were eluci-
dated at 3 A˚ resolution. Subsequently, in 2016, the crystal
structure of Cascade bound to a PAM-containing dsDNA
target was determined at 2.5 A˚ resolution [17]. These
high-resolution crystal structures provided mechanistic
insights into the crRNP assembly and crRNA-guided
target interference in the type I surveillance complex.
The overall architecture of Cascade can be divided into
two helical filaments [14,15,16,17] (Figure 2a,b).
The first and second filaments are formed by Cas6e–
Cas7.1–Cas7.6–Cas5e and Cse2.1–Cse2.2–Cse1, respec-
tively. The body of the complex consists of the backbone
formed by Cas7.1–Cas7.6 and the belly formed by the
Cse2.1–Cse2.2 dimer. The 61-nt crRNA consists of the
spacer-derived, 32-nt guide segment flanked by the re-
peat-derived 50 and 30 handles (Figure 2a). The 8-nt 50
handle adopts an S-shaped conformation, and is recog-
nized by Cse1, Cas5e and Cas7.6 at the tail (Figure 2b).
The 21-nt 30 handle has a palindromic sequence and thus
forms a stem-loop structure, which is recognized by Cas6e
at the head (Figure 2b). Cas6e selectively cleaves the
stem-loop structure in the pre-crRNA repeats to produce
mature crRNAs, and remains tightly bound to them [18].
These observations suggest that Cas6e serves as a plat-
form for the complex assembly.
Intriguingly, Cas7.1 and Cas7.6 interact with Cas6e
and Cas5e, respectively, in distinct manners from those
observed between the other adjacent Cas7 subunitswww.sciencedirect.com (Cas7.2–Cas7.5), thereby enabling the unified assembly
of the Cascade complex (Figure 2b). Cas5e, Cas6e and
Cas7 contain the modified RNA-recognition motif (RRM),
and form a right-hand-like structure consisting of the
palm, finger and thumb regions (Figure 2c–e). In
Cas7.2–Cas7.5, the palm and thumb of one subunit inter-
act with the palm of the adjacent Cas7 subunit (Figure 2c).
The thumbs of Cas7.2–Cas7.5 adopt a b-hairpin confor-
mation, which intercalates within the guide-target hybrid
and interacts with the fingers of the adjacent Cas7 subunit
(Figure 2f). By contrast, the thumb of Cas7.1 forms a short
helix and interacts with Cas6e (Figure 2d). The finger of
Cas7.6 rotates as a rigid body, and interacts with Cas5e to
create the binding pocket for the 50 crRNA handle
(Figure 2e). In the structures of Cascade alone, the crRNA
guide segment is recognized by the Cas7 subunits in a
non-sequence-specific manner, with their Watson-Crick
edges available for base pairing with the target DNA
[14,15]. In the structures of Cascade bound to a
DNA target, the crRNA and target DNA strand adopt
an unwound ribbon-like conformation resembling a lad-
der, which is bound to the cleft between the two helical
filaments [16,17] (Figure 2f). The crRNA–DNA hy-
brid consists of five 5-bp segments separated by 1-bp gaps,
which are induced by the thumb-like b-hairpins in the
Cas7 subunits [16,17].
The PAM-containing duplex is wrapped around Cse1,
Cas7.5 and Cas7.6 [17] (Figure 2g). The 50-ATG-30
PAM on the non-target strand is recognized by Cse1 from
the minor groove side, explaining why the five PAM
sequences (ATG, AAG, AGG, GAG and TAG) canCurrent Opinion in Structural Biology 2017, 43:68–78
70 Macromolecular assemblies
Figure 2
G
ui
de
PA
M
Cas3
Ca
s7
.6
Ca
s7
.5
Ca
s7
.4
Ca
s7
.3
Ca
s7
.2
Ca
s7
.1
Ca
s5
e
Cs
e1
Cs
e2
.2
Cs
e2
.1
Cas6e
3′
3′
3′
5′
5′
5′
NTSTS
5′ handle
3′ handle
Cse1 Cse1
Cse1-NTD
Cse1-CTD
Cas7.6 Cas7.6
Cas5e
Cas7.6
Cas7.6
Cas7.5
Cas7.5
Cas3
HD
Linker ssDNA
RecA1
RecA2 CTD
Cas7.2
Cas7.2
Cas7.3
Cas7.3
Finger
Finger
Palm
Palm
Thumb
Thumb
ThumbCas6e
Cas7.1
Finger
Palm
Thumb
Cas5e Cas7.6
Finger
Palm
Cas7.4
Cas7.5 Cas7.5Cse2.2
Cse2.2
Cse2.1 Cse2.1
Cas7.2 Cas7.2
Cas7.1 Cas7.1
Cas7.3 Cas7.3
Cas7.4
Cas7.4
Cas6e Cas6e
5′ handle
3′ handle
3′ handle 3′ handle
Guide
TS
NTS
TS
180º
5′
3′
5′
5′
3′
5′
3′
3′
5′
5′
5′
5′
3′
3′
3′
3′
3′
5′ handle
(a) (b)
(f)
(c) (d) (e)
(g) (h)
Current Opinion in Structural Biology
Type I Cascade-Cas3 effector complex. (a) Target interference mechanism. The thumb-like b-hairpins in the Cas7 subunits are depicted as
magenta circles. TS, target DNA strand; NTS, non-target DNA strand. (b) Crystal structure of Cascade bound to a dsDNA target (PDB: 5H9F). The
structural images were prepared using CueMol (http://www.cuemol.org). (c) Interaction between Cas7.2 and Cas7.3 (PDB: 1VY8). (d) Interaction
between Cas6e and Cas7.1 (PDB: 1VY8). (e) Interaction between Cas5e and Cas7.6 (PDB: 1VY8). (f) Recognition of the guide-target hybrid (PDB:
5H9F). The thumb-like b-hairpins in the Cas7 subunits are highlighted in magenta. (g) Recognition of the PAM and the R-loop (PDB: 5H9F). Cse1-
CTD is highlighted in orange. The PAM is highlighted in purple. (h) Crystal structure of ssDNA-bound Cas3 (PDB: 4QQW).
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DNA strand is bound to the cleft between the Cse1-NTD
(N-terminal domain) and the Cse1-CTD (C-terminal
domain), which locks the R-loop in place (Figure 2g).
A structural comparison between Cascade alone and the
R-loop complex revealed conformational changes in
Cse1, Cse2.1 and Cse2.2 [16,17]. Importantly, a local
conformational change occurs at the interface between
the Cse1-NTD and the Cse1-CTD, consistent with pre-
vious data showing that Cas3 is recruited to the Cse1
subunit upon R-loop formation [12,19]. The crystal struc-
tures of Cas3 revealed that it consists of four domains, the
HD nuclease, the superfamily-2 helicase (RecA1 and
RecA2), the linker and the C-terminal domains, and that
the 50 and 30 ends of the ssDNA are bound at the RecA2
helicase and HD nuclease domains, respectively [20,21]
(Figure 2h). Mutational analyses revealed that the linker
and C-terminal domains are involved in the association
with Cascade [21].
Since the available DNA-bound Cascade structure con-
tains a forked DNA substrate, rather than a dsDNA
duplex unwound by crRNA-guided strand invasion, the
elucidation of the structure of Cascade bound to dsDNA
is important to clarify the mechanism of dsDNA unwind-
ing and the location of the displaced strand. In addition,
the structural determination of the Cascade–DNA–Cas3
complex at high resolution will be an important challenge
in future studies.
Type III Csm/Cmr effector complex
The type III CRISPR-Cas system comprises two sub-
types (III-A and III-B). The type III-A Csm effector
complex consists of five Cas protein subunits (Csm1–
Csm5) and a crRNA, with a stoichiometry of
Csm1123364251-crRNA1 [22,23]. The type III-B Cmr ef-
fector complex has six Cas protein subunits (Cmr1–Cmr6)
and a 45-nt crRNA, with a stoichiometry of
Cmr112131445361-crRNA1 (Cmr112131435261 with a 39-
nt crRNA) [24–26] (Figure 3a). Initial studies indicated
that the Csm and Cmr complexes target DNA and RNA,
respectively [22,24]. However, recent studies revealed
that the type III effector complexes have dual nuclease
activities, crRNA-guided ssRNase and target ssRNA-
activated ssDNase, and physiologically function as tran-
scription-dependent DNA nucleases [27–31] (Figure 3a).
The Cas7 family subunits, Csm3 and Cmr4, cleave
ssRNAs complementary to the spacer-derived guide seg-
ment in the crRNA at discrete 6-nt intervals in the type
III-A [23,28,32] and type III-B [26,33–36] systems, re-
spectively. By contrast, the Cas10 family subunits, Csm1
and Cmr2, cleave ssDNA in a target ssRNA-dependent
manner in the type III-A [28] and type III-B [29,30]
systems, respectively.
In 2013–2014, the cryo-EM reconstructions of the Csm
complexes from Thermus thermophilus [23] and Sulfolobuswww.sciencedirect.com solfataricus [37] and the Cmr complexes from T. thermo-
philus [26] and Pyrococcus furiosus [25,35], together with
the crystal structures of the individual subunits of the P.
furiosus Cmr complex [33], revealed the architectural
similarity between the type III effector complexes and
the type I Cascade complex. In 2015, the higher-resolu-
tion cryo-EM structure of the T. thermophilus Cmr com-
plex [38], and the 2.1 A˚ resolution crystal structure of the
chimeric Cmr complex bound to a crRNA and a non-
cleavable ssDNA target [39] provided detailed structur-
al information about the type III effector complexes.
The chimeric Cmr complex contained P. furiosus Cmr2–
Cmr3 and Archaeoglobus fulgidus Cmr43–Cmr52–Cmr61,
for crystallization [39]. The Cmr complex adopts a
worm-like architecture, and can be divided into two
helical filaments (Figure 3a,b). The first filament is
formed by the Cmr3, Cmr4.1–Cmr4.3 and Cmr6 subunits.
Cmr4 contains the modified RRM and adopts a right-
hand-like structure (Figure 3c). The three Cmr4 subunits
(Cmr4.1–Cmr4.3) form a helical stack. Cmr3 and Cmr6
also contain the modified RRM, and adopt similar right-
hand-like structures (Cmr3 has two RRMs and consists of
Cmr3-NTD and Cmr3-CTD) (Figure 3d–f). Therefore,
Cmr4.1 and Cmr4.3 stack with Cmr6 and Cmr3-NTD in a
similar manner to those of the adjacent Cmr4 subunits,
respectively (Figure 3b). The second filament is formed
by Cmr2 and the Cmr5.1–Cmr5.2 dimer. Cmr5.1 is
capped by Cmr6 in the first filament, while Cmr5.2
interacts with the Cmr2 D4 domain, which shares struc-
tural similarity with Cmr5 (Figure 3b,g). The crRNA–
target hybrid is accommodated between the two fila-
ments.
The 39-nt crRNA consists of the spacer-derived, 31-nt
guide segment, and the repeat-derived, 8-nt 50 handle
(also known as the 50 tag) [39] (Figure 3a). The 50 handle
adopts an S-shaped conformation, and is recognized by
Cmr3 and Cmr4.3 in a sequence-specific manner
(Figure 3g). By contrast, the crRNA guide segment is
recognized by Cmr4.1–Cmr4.3 and Cmr6 in a non-se-
quence-specific manner. Notably, the Cmr4 thumb
regions form b-hairpins and intercalate within the
guide-target duplex, resulting in base flipping at 6-nt
intervals and placing the scissile phosphate groups in
the target strand near the catalytic Asp31 residues in
Cmr4.1–Cmr4.3 [39] (Figure 3h). These structural fea-
tures elegantly explain the mechanism underlying the
periodic target cleavage by the Cmr complex.
The structural similarities between the Cascade and Cmr
complexes suggest the divergent evolution of the type I
and type III effectors from a common ancestor [40],
consistent with an earlier study noting the resemblance
between the type I and type III effectors [41]. Cmr3 and
Cmr4 share sequence and functional similarities with
Cas5 and Cas7 in Cascade, respectively. Cmr2 andCurrent Opinion in Structural Biology 2017, 43:68–78
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Type III Cmr effector complex. (a) Target interference mechanism. The thumb-like b-hairpins in the Cmr4 subunits are depicted as magenta
circles. The cleavage sites are indicated by yellow triangles. Cmr1 is not included in the crystal structure of the chimeric Cmr complex, and is
indicated by a dashed box. This Cmr complex represents the 39-nt crRNA-bound smaller species, which lacks one set of the Cmr4-Cmr5
subunits, as compared with the 45-nt crRNA-bound intact Cmr complex. TS, template DNA strand; NTS, non-template DNA strand; RNAP, RNA
polymerase. (b) Crystal structure of the chimeric Cmr complex bound to a crRNA and a non-cleavable ssDNA target (PDB: 3X1L). The complex
lacks the Cmr1 subunit and the HD domain in the Cmr2 subunit. (c–f) Structures of Cmr4 (c), Cmr3-NTD (d), Cmr3-CTD (e), and Cmr6 (f). (g,h)
Recognition of the guide-target hybrid. In (g), the HD nuclease domain from the intact Cmr2 structure (PDB: 4W8Y) is shown. The HD and D4
domains in Cmr2 are highlighted in sky blue and green, respectively. In (h), the thumb-like b-hairpins in the Cmr4 and Cmr3 subunits are
highlighted in magenta. The Asp31 residues in Cmr4 are shown as stick models, and the cleavage sites are indicated by yellow triangles.Cmr5 are located at positions corresponding to those of
Cse1 and Cse2 in Cascade, respectively, despite the lack
of sequence similarities between them. However, notable
structural differences also exist between the type I and
type III effectors, consistent with their striking mecha-
nistic differences. Cmr4 and Cmr5 create sharp kinks in
the target RNA strand for cleavage, by contrast to the
interactions of Cas7 and Cse2 in Cascade [39]
(Figure 3h). In addition, Cas7 lacks a catalytic aspartateCurrent Opinion in Structural Biology 2017, 43:68–78 residue corresponding to Asp31 in Cmr4. These structural
differences explain why the Cmr complex, but not the
Cascade complex, catalyzes crRNA-guided target cleav-
age.
The mechanism of DNA cleavage by the type III effec-
tors remains unclear. Recent studies showed that (1) the
Cmr2 HD domain cleaves the target ssDNA, (2)
the ssDNA cleavage requires the base pairing betweenwww.sciencedirect.com
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ssDNA, but not ssRNA, is inhibited by base pairing
between the crRNA 50 handle and the target ssRNA
[29,30]. In addition, the ssDNA cleavage requires the
presence of the PAM in the target ssRNA [29]. The
crystal structure of the Cmr complex contained the
guide-target hybrid, and thus likely represents a compe-
tent conformation for ssDNA cleavage, although the HD
domain was truncated for crystallization [39]. In the
Cmr complex structure, Cmr2 is located in the vicinity of
the crRNA 50 handle and the target ssRNA (Figure 3g),
suggesting that Cmr2 can adopt distinct conformations
depending on the guide-target base pairing. Thus, the
structural determination of a target RNA-free Cmr com-
plex, and a comparison between the Cmr structures with
and without the target ssRNA, will shed light on the
RNA-activated ssDNA cleavage mechanism. In addition,
a higher-resolution structure of the Csm complex will
advance our mechanistic understanding of the type III
effector nucleases.
Class 2 system
Type II Cas9 effector complex
In the type II CRISPR-Cas system, the dual RNA-guided
DNA endonuclease Cas9 is responsible for the target
degradation [42,43]. In 2010, an in vivo investigation of
the Streptococcus thermophilus CRISPR-Cas system indi-
cated that Cas9 cleaves both strands of the DNA target
[42]. In 2011, an in vivo study of the Streptococcus pyogenes
CRISPR-Cas system revealed that the tracrRNA (trans-
activating crRNA), a trans-encoded small RNA, is critical
for the crRNA maturation and immunity against lysogenic
phages in the type II system [43]. In 2012, biochemical
studies demonstrated that Cas9 forms an effector com-
plex with a crRNA and a tracrRNA, and cleaves dsDNA
targets complementary to the crRNA guide to generate
blunt ends [44,45] (Figure 4a,b). Cas9 has two endonu-
clease domains, HNH and RuvC. The HNH domain
cleaves the DNA strand complementary to the crRNA
guide (target DNA strand), while the RuvC domain
cleaves the displaced, single-stranded DNA strand
(non-target DNA strand). Cas9 also requires a PAM on
the non-target strand for the dsDNA recognition. Impor-
tantly, a single-guide RNA (sgRNA), in which the crRNA
30 end and the tracrRNA 50 end are connected by a
tetraloop, can direct Cas9 to target cleavage [44]. In
2013, a series of studies demonstrated that the simple
two-component system, consisting of S. pyogenes Cas9
(SpCas9) and its sgRNA, showed robust activity in mam-
malian cells [46–48], and the SpCas9–sgRNA system is
now widely used as a genome engineering tool.
In 2014–2016, numerous structural studies greatly ad-
vanced our understanding of the RNA-guided DNA
cleavage by Cas9. In 2014, the crystal structures of
SpCas9 and Actinomyces naeslundii Cas9 in the apo
states revealed that Cas9 adopts a bilobed architecturewww.sciencedirect.com comprising an a-helical lobe and a nuclease-containing
lobe [49]. Furthermore, the EM reconstructions of the
SpCas9–RNA and SpCas9–RNA–DNA complexes dem-
onstrated that crRNA:tracrRNA binding induces a closed-
to-open structural change in the Cas9 protein [49].
Almost simultaneously, the crystal structure of the
SpCas9–sgRNA–ssDNA complex revealed the atomic
details of the recognition mechanism of the sgRNA and
its target DNA [50]. Subsequently, the PAM recognition
mechanism was elucidated by analyses of the crystal
structure of SpCas9 bound to the sgRNA and a PAM-
containing DNA [51]. More recently, the structures of
the SpCas9–sgRNA binary complex [52] and SpCas9–
sgRNA bound to an R-loop [53] have provided further
insights into the RNA-guided DNA cleavage by Cas9.
Cas9 adopts a bilobed architecture, comprising recogni-
tion (REC) and nuclease (NUC) lobes (Figure 4a–c). The
REC lobe is responsible for the nucleic-acid recognition,
and can be divided into three a-helical domains (REC1–
REC3). The NUC lobe contains the HNH and RuvC
nuclease domains, and a C-terminal region consisting of
the Wedge (WED) and PAM-interacting (PI) domains.
The REC, WED and PI domains are unique to the Cas9
family protein, and lack structural similarity with other
known proteins. The crRNA consists of the 20-nt spacer-
derived guide segment and the 12-nt repeat-derived
region, while the tracrRNA includes the 14-nt anti-repeat
region and the 30 tail (Figure 4b,d). The crRNA repeat
region and the tracrRNA anti-repeat region form a partial
duplex structure, which is recognized by the REC and
WED domains (Figure 4c,d). The tracrRNA 30 tail con-
tains three stem-loop structures, which are extensively
recognized by Cas9, thereby contributing to the stable
complex assembly [50]. The crRNA guide segment and
the target DNA strand form the heteroduplex, which is
bound to the central channel between the two lobes. The
PAM-containing duplex is bound to the groove formed by
the WED and PI domains, in which the 50-NGG-30 PAM
is recognized from the major-groove side by a pair of
arginine residues in the PI domain [51] (Figure 4c). The
crRNA ‘seed’ region, which is important for the Cas9-
mediated DNA recognition, is extensively recognized by
the conserved arginine cluster in the bridge helix
between the two lobes [50]. Furthermore, the
SpCas9–sgRNA structure revealed that the ‘seed’ region
is preordered in an A-form conformation, thus facilitating
efficient base-pairing with a target DNA [52]. In the
SpCas9–sgRNA–DNA structures, the RuvC domain is
located at the position suitable for cleaving the non-target
strand, whereas the HNH domain is farther away from the
target strand [50,51] (Figure 4c), indicating that a
conformational change affecting the HNH domain is
required for target cleavage. Indeed, the structures of
the SpCas9 R-loop complex revealed that the R-loop
formation induces drastic conformational changes in
the linker regions between the two nuclease domains,Current Opinion in Structural Biology 2017, 43:68–78
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Type II Cas9 effector complex. (a) Domain structure of SpCas9. BH, bridge helix. (b) Target interference mechanism. The cleavage sites are
indicated by yellow triangles. TS, target DNA strand; NTS, non-target DNA strand. (c) Crystal structure of the SpCas9–sgRNA–DNA complex
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[53]. Consistent with these structural studies, intramo-
lecular Fo¨rster resonance energy transfer experiments
revealed the conformational dynamics of the HNH do-
main during target cleavage [54].Current Opinion in Structural Biology 2017, 43:68–78 The Cas9 orthologs from different microbes have diverse
sequences and sizes, and function with their cognate
crRNA:tracrRNA guides [55,56]. In addition, the Cas9
orthologs recognize a variety of PAM sequences. The
crystal structures of Cas9 orthologs, such as the smallerwww.sciencedirect.com
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larger Cas9 from Francisella novicida (FnCas9) [58],
illuminated the structural diversity among the ortholo-
gous CRISPR-Cas9 systems (Figure 4e,f). A structural
comparison of SpCas9, SaCas9 and FnCas9 revealed that,
although they share the conserved nuclease domains,
their REC and WED domains are structurally diverseFigure 5
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cognate guide RNAs, thereby defining the orthogonality
between the cognate Cas9 and guide RNA pairs.
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helix. (b) Target interference mechanism. The cleavage sites are
strand. (c) Crystal structure of the AsCpf1–crRNA–DNA complex (PDB:
DNA complex (PDB: 5B43). (e) Crystal structure of the LbCpf1–crRNA
bCpf1 (pale blue). The structural differences are depicted by orange
Current Opinion in Structural Biology 2017, 43:68–78
76 Macromolecular assembliesRuvC domains precisely cleave the target and non-target
strands at the position 3-nt upstream of the PAM, respec-
tively. In addition, the mechanisms by which the highly
divergent Cas9 orthologs specifically recognize their cog-
nate guide RNA and the PAM sequence remain to be
clarified. Answering these questions will require future
structural studies.
Type V Cpf1 effector complex
In 2015, a prominent study revealed that Cpf1 is the type
V effector nuclease that generates a double-strand break
at a DNA target complementary to the crRNA guide [59]
(Figure 5a,b). Cpf1 orthologs, such as Acidaminococcus sp.
Cpf1 (AsCpf1) and Lachnospiraceae bacterium Cpf1
(LbCpf1), exhibit robust activities in mammalian cells,
and have been utilized for genome editing [59]. There are
notable functional differences between the two class
2 effector nucleases, Cas9 and Cpf1. First, Cpf1 functions
with a single crRNA, and does not require a tracrRNA.
Second, Cpf1 recognizes a T-rich PAM. Third, Cpf1
cleaves a target DNA at the PAM-distal site, to create
staggered ends. Fourth, Cpf1 contains the RuvC domain,
but lacks a detectable second nuclease domain. Fifth,
Cpf1 also participates in crRNA processing [60].
In 2016, the crystal structures of LbCpf1 in complex
with a crRNA [61] and AsCpf1 in complex with a
crRNA and its target DNA [62,63] were determined.
The structures revealed that Cpf1 adopts a bilobed
architecture consisting of the REC and NUC lobes,
with the crRNA-target DNA heteroduplex bound to
the central channel between the two lobes [62,63]
(Figure 5a–c). The REC lobe consists of two a-helical
domains (REC1 and REC2), and participates in nucleic-
acid recognition. The NUC lobe can be divided into
four domains, the WED, PI, RuvC and Nuc domains.
The REC, WED and PI domains of Cpf1 perform
functional roles similar to those of Cas9, although they
lack sequence and structural similarities with their
counterparts in Cas9. The crRNA consists of the 24-
nt spacer-derived guide segment and the 19-nt repeat-
derived 50 handle (Figure 5b,d). Unexpectedly, the
crystal structures revealed that the guide segment and
the target DNA strand form a 20-bp, rather than 24-bp,
heteroduplex, which is recognized within the REC lobe
[62,63] (Figure 5c,d). The crRNA 50 handle forms a
pseudoknot structure, and is recognized by the WED
and RuvC domains (Figure 5c,d). The PAM-containing
duplex adopts a distorted conformation with a narrow
minor groove, and is surrounded by the WED, REC1
and PI domains. The 50-TTTN-30 PAM is recognized
from the major and minor groove sides by the WED-
REC1 and PI domains, respectively, via base and shape
readout mechanisms [62]. The RuvC domain is locat-
ed at the position suitable to cleave the non-target DNA
strand at the PAM-distal site (Figure 5c). Importantly,
mutational analyses revealed that the Nuc domain isCurrent Opinion in Structural Biology 2017, 43:68–78 involved in the target strand cleavage, and thus the Nuc
domain is the second nuclease domain that is function-
ally analogous, but not homologous, to the HNH nucle-
ase domain of Cas9 [62].
AsCpf1 and LbCpf1 share similar bilobed architectures
[61,62,63] (Figure 5c,e). Negative staining EM dem-
onstrated that LbCpf1 adopts an elongated structure in
the absence of the crRNA, indicating the crRNA-induced
conformational changes in Cpf1 [61]. In addition, a
structural comparison between LbCpf1–crRNA and
AsCpf1–crRNA–DNA revealed the occurrence of confor-
mational changes upon the RNA–DNA heteroduplex
formation (Figure 5f). Furthermore, a comparison of
the Cpf1 and Cas9 structures highlighted the structural
and mechanistic convergence between the two class
2 effector nucleases [62].
Despite marked advances in our mechanistic under-
standing of Cpf1-mediated DNA recognition, many in-
triguing questions remain unanswered. Curiously, the
inactivating mutations in the RuvC domain abrogated
the target strand cleavage by the Nuc domain [59,62],
indicating that the RuvC-mediated non-target strand
cleavage is required for the Nuc-mediated target strand
cleavage. In addition, the mechanism of the Cpf1-medi-
ated crRNA processing still remains enigmatic, although
three conserved residues in the WED domain are in-
volved in the crRNA processing [60]. Further structural
and functional studies will provide the answers to these
important questions.
Conclusions
Over the past few years, numerous studies have improved
our understanding of the molecular mechanisms of
crRNA-guided target recognition and cleavage in the
different types of CRISPR-Cas systems. Given the rapid
pace of progress in this field and the recent technical
breakthroughs in cryo-EM, future structural studies are
expected to provide new insights into the actions of the
crRNP effector nucleases. Furthermore, novel crRNA-
guide effectors, such as the recently characterized C2c1,
C2c2 and C2c3 [6,64,65], may be discovered in future
studies. The structural information about such new
crRNPs will clarify the mechanistic diversity of the
CRISPR-Cas systems, and accelerate the development
of novel genome engineering technologies.
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